Cargando…

In vivo CRISPR editing with no detectable genome-wide off-target mutations

Detalles Bibliográficos
Autores principales:	Akcakaya, Pinar, Bobbin, Maggie L., Guo, Jimmy A., Malagon-Lopez, Jose, Clement, Kendell, Garcia, Sara P., Fellows, Mick D., Porritt, Michelle J., Firth, Mike A., Carreras, Alba, Baccega, Tania, Seeliger, Frank, Bjursell, Mikael, Tsai, Shengdar Q., Nguyen, Nhu T., Nitsch, Roberto, Mayr, Lorenz M., Pinello, Luca, Bohlooly-Y, Mohammad, Aryee, Martin J., Maresca, Marcello, Joung, J. Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194229/ https://www.ncbi.nlm.nih.gov/pubmed/30209390 http://dx.doi.org/10.1038/s41586-018-0500-9

Ejemplares similares

In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
por: Carreras, Alba, et al.
Publicado: (2019)

Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype
por: Bjursell, Mikael, et al.
Publicado: (2018)

CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets
por: Tsai, Shengdar Q., et al.
Publicado: (2017)

Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing
por: Kleinstiver, Benjamin P., et al.
Publicado: (2019)

Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery
por: Lundin, Anders, et al.
Publicado: (2020)

Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells
por: Kleinstiver, Benjamin P., et al.
Publicado: (2016)

Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation
por: Bjursell, Mikael, et al.
Publicado: (2016)

GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
por: Tsai, Shengdar Q., et al.
Publicado: (2014)

Decoding non-random mutational signatures at Cas9 targeted sites
por: Taheri-Ghahfarokhi, Amir, et al.
Publicado: (2018)

RNA interference approaches for treatment of HIV-1 infection
por: Bobbin, Maggie L, et al.
Publicado: (2015)

Engineered CRISPR-Cas9 nucleases with altered PAM specificities
por: Kleinstiver, Benjamin P., et al.
Publicado: (2015)

An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities
por: Gehrke, Jason M., et al.
Publicado: (2018)

AmpUMI: design and analysis of unique molecular identifiers for deep amplicon sequencing
por: Clement, Kendell, et al.
Publicado: (2018)

High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets
por: Kleinstiver, Benjamin P., et al.
Publicado: (2016)

Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
por: Tsai, Shengdar Q., et al.
Publicado: (2014)

Current Progress of RNA Aptamer-Based Therapeutics
por: Zhou, Jiehua, et al.
Publicado: (2012)

IDOL regulates systemic energy balance through control of neuronal VLDLR expression
por: Lee, Stephen D., et al.
Publicado: (2019)

Augmenting and directing long-range CRISPR-mediated activation in human cells
por: Tak, Y. Esther, et al.
Publicado: (2021)

Precision digital mapping of endogenous and induced genomic DNA breaks by INDUCE-seq
por: Dobbs, Felix M., et al.
Publicado: (2022)

Universal toxin-based selection for precise genome engineering in human cells
por: Li, Songyuan, et al.
Publicado: (2021)

Author Correction: Universal toxin-based selection for precise genome engineering in human cells
por: Li, Songyuan, et al.
Publicado: (2021)

A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo
por: Bestas, Burcu, et al.
Publicado: (2023)

Ageing Fxr Deficient Mice Develop Increased Energy Expenditure, Improved Glucose Control and Liver Damage Resembling NASH
por: Bjursell, Mikael, et al.
Publicado: (2013)

Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing
por: Wimberger, Sandra, et al.
Publicado: (2023)

Metabolic Parameters and Emotionality Are Little Affected in G-Protein Coupled Receptor 12 (Gpr12) Mutant Mice
por: Frank, Elisabeth, et al.
Publicado: (2012)

Ghrelin increases intake of rewarding food in rodents
por: Egecioglu, Emil, et al.
Publicado: (2010)

FLASH Assembly of TALENs Enables High-Throughput Genome Editing
por: Reyon, Deepak, et al.
Publicado: (2012)

To determine whether the first file to bind at the working length corresponds to the apical diameter in roots with apical curvatures both before and after preflaring
por: Dillon, Jaidev Singh, et al.
Publicado: (2012)

CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells
por: Petri, Karl, et al.
Publicado: (2022)

Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells
por: Liao, Jing, et al.
Publicado: (2015)

The COVID-19 pandemic as disjuncture: Lifelong learning in a context of fear
por: Bjursell, Cecilia
Publicado: (2020)

Growth Through Education: The Narratives of Older Adults
por: Bjursell, Cecilia
Publicado: (2019)

A Code of Ethics for Gene Drive Research
por: Annas, George J., et al.
Publicado: (2021)

ADAMTS-1 in abdominal aortic aneurysm
por: Vorkapic, Emina, et al.
Publicado: (2017)

Comparative evaluation of efficacy of different irrigation devices in removal of calcium hydroxide in teeth with simulated internal resorption cavities – An in vitro study
por: Arora, Roshni, et al.
Publicado: (2022)

Assessment of computational methods for the analysis of single-cell ATAC-seq data
por: Chen, Huidong, et al.
Publicado: (2019)

Broad Specificity Profiling of TALENs Results in Engineered Nucleases With Improved DNA Cleavage Specificity
por: Guilinger, John P., et al.
Publicado: (2014)

Rapid target validation in a Cas9-inducible hiPSC derived kidney model
por: Shamshirgaran, Yasaman, et al.
Publicado: (2021)

Monoclonal Antibody Targeting of Fibroblast Growth Factor Receptor 1c Ameliorates Obesity and Glucose Intolerance via Central Mechanisms
por: Lelliott, Christopher J., et al.
Publicado: (2014)

Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models
por: Hacken, Elisa ten, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_81t2btbho5uuhafk186b9j30gr